|
Volumn 20, Issue 22, 2010, Pages 6854-6857
|
Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold
|
Author keywords
HIV; Integrase inhibition; Pyrazolone scaffold
|
Indexed keywords
3 BROMOPHENYL;
3 CHLOROPHENYL;
3 FLUOROPHENYL;
3 IODOPHENYL;
3 NITROPHENYL;
3 PHENYLPHENYL;
3 TOLYL;
3 TRIFLUOROMETHYLPHENYL;
3,5 DICHLOROPHENYL;
4 BROMOPHENYL;
4 CARBOXYLPHENYL;
4 IODOPHENYL;
4 SULFONYAMIDOPHENYL;
BENZOTHIAZOLYL;
CARBOXYLIC ACID;
CARBOXYLIC ACID ETHYL ESTER;
ELVITEGRAVIR;
ETHYL 6 DEOXY 3,5 DI O METHYL 6 (3 METHYL 3 NITROSOUREIDO) ALPHA GLUCOFURANOSIDE;
HOMOACETATE;
HYDRAZINE;
INTEGRASE INHIBITOR;
METHYL HOMOACETATE;
METHYLENE BLUE;
PHENYL GROUP;
PYRAZOLONE;
TRIFLUOROACETAMIDE DERIVATIVE;
TRIFLUOROMETHYL;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING AFFINITY;
CYCLIZATION;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG SYNTHESIS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IC 50;
IN VITRO STUDY;
PHARMACOPHORE;
STRUCTURE ACTIVITY RELATION;
CATALYSIS;
HIV INTEGRASE INHIBITORS;
HIV-1;
MODELS, MOLECULAR;
MUTATION;
PYRAZOLONES;
STRUCTURE-ACTIVITY RELATIONSHIP;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 77958035040
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.08.057 Document Type: Article |
Times cited : (99)
|
References (16)
|